Patient-Derived Organoids in Precision Medicine: Drug Screening, Organoid-on-a-Chip and Living Organoid Biobank

Overview of attention for article published in Frontiers in oncology, December 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (87th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

So far, Altmetric has seen 6 X posts from 5 X users, with an upper bound of 10,225 followers.

RT @Swiss3RCC: Patient-derived #organoids (PDO) are becoming a popular tool for #personalizedmedicine and the prediction of patients’ respo…

RT @Swiss3RCC: Patient-derived #organoids (PDO) are becoming a popular tool for #personalizedmedicine and the prediction of patients’ respo…

Patient-derived #organoids (PDO) are becoming a popular tool for #personalizedmedicine and the prediction of patients’ responses to therapeutic interventions. Reviewed in Zhou et al. #replacement #3Rs #treatmentoutcome https://t.co/HwWEVsTk3m @FrontiersIn

#1: Patient-Derived #Organoids in #PrecisionMedicine: Drug Screening, Organoid-on-a-Chip and Living Organoid Biobank 👩‍⚕️👨‍⚕️ Zilong Zhou, Lele Cong & Xianling Cong Read now 👉 https://t.co/nWxdRnJqoJ #Oncology #MedOnc #ClinOnc

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.